
Reset all filters
01 1SperaNexus Inc.
Reset all filters
01 1Tosylate suplatast
Reset all filters
01 1Japan
Registration Number : 218MF10274
Registrant's Address : 4-8-2 Nihonbashi Honcho, Chuo-ku, Tokyo
Initial Date of Registration : 2006-02-23
Latest Date of Registration : 2006-10-20
93
PharmaCompass offers a list of Suplatast API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Suplatast manufacturer or Suplatast supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Suplatast manufacturer or Suplatast supplier.
PharmaCompass also assists you with knowing the Suplatast API Price utilized in the formulation of products. Suplatast API Price is not always fixed or binding as the Suplatast Price is obtained through a variety of data sources. The Suplatast Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Suplatast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suplatast, including repackagers and relabelers. The FDA regulates Suplatast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suplatast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Suplatast supplier is an individual or a company that provides Suplatast active pharmaceutical ingredient (API) or Suplatast finished formulations upon request. The Suplatast suppliers may include Suplatast API manufacturers, exporters, distributors and traders.
click here to find a list of Suplatast suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Suplatast Drug Master File in Japan (Suplatast JDMF) empowers Suplatast API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Suplatast JDMF during the approval evaluation for pharmaceutical products. At the time of Suplatast JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Suplatast suppliers with JDMF on PharmaCompass.
We have 1 companies offering Suplatast
Get in contact with the supplier of your choice: